BlinkRx · 4 hours ago
Senior Financial Analyst
Blink Health is the fastest growing healthcare technology company that builds products to make prescriptions accessible and affordable to everybody. The Senior Financial Analyst will drive financial insights, support strategic decision-making, and improve financial performance across the organization.
AppsE-CommerceHealth CareOnline PortalsPharmaceutical
Responsibilities
Own financial modeling, forecasting, and reporting processes
Develop and maintain financial models to support business cases, strategic initiatives, and pricing decisions
Analyze financial performance against plan, prior periods, and key drivers; clearly communicate insights and risks
Partner with cross-functional stakeholders (e.g., Operations, Product, Sales, Data, Accounting) to support decision-making
Prepare management reporting, dashboards, and presentations for senior leadership
Identify opportunities to improve financial processes, reporting accuracy, and efficiency
Support month-end close activities, including variance analysis and accruals (as applicable)
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or a related field
5+ years of experience in financial analysis, FP&A, or a related role
Strong financial modeling, forecasting, and analytical skills
Advanced proficiency in Excel; experience with financial systems and BI tools
Ability to translate complex financial data into clear, actionable insights
Strong communication skills and comfort working with senior stakeholders
Experience working with large data sets and Tableau/SQL
Strong attention to detail and can establish thorough project plans and deliver against committed timelines
Preferred
MBA is a plus
Prior experience in the healthcare industry is a plus, but not required
Company
BlinkRx
BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.
Funding
Current Stage
Late StageTotal Funding
$315MKey Investors
1789 CapitalSuRo Capital8VC
2024-11-16Series D· $140M
2020-10-27Series Unknown· $10M
2017-04-12Series B· $90M
Recent News
2026-01-06
2025-12-11
Company data provided by crunchbase